Express Scripts Holding Company (ESRX) was Downgraded by Wells Fargo to ” Underperform”. Earlier the firm had a rating of “Market Perform ” on the company shares. Wells Fargo advised their Clients and Investors in a research report released on Mar 15, 2017.
Based on several research reports , Express Scripts Holding Company was Downgraded by Wells Fargo to ” Underperform” on Mar 15, 2017.
Several company insiders have filed Insider transactions , on Mar 2, 2017, Everett Neville (Sr VP-Supply Chain & Specialty) sold 2,352 shares at $70.16 per share price. According to the SEC, on Nov 14, 2016, Steven B Miller (Sr. VP & Chief Med. Officer) sold 21,798 shares at $75.02 per share price. On Nov 14, 2016, Phyllis S. Anderson (Sr. VP & Ch. Marketing Officer) sold 642 shares at $74.74 per share price, according to the Form-4 filing with the securities and exchange commission.
On the company’s financial health, Express Scripts Holding Company reported $1.88 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Feb 14, 2017. Analyst had a consensus of $1.87. The company had revenue of $24863.30 million for the quarter, compared to analysts expectations of $26287.35 million. The company’s revenue was down -5.0 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.56 EPS.
Express Scripts Holding Company closed down -0.78 points or -1.17% at $66.06 with 69,37,942 shares getting traded on Wednesday. Post opening the session at $65.8, the shares hit an intraday low of $65.26 and an intraday high of $66.67 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.